Cell separation technologies comprise the cells’ isolation from a heterogeneous cell mixture as per their extracellular or intracellular characteristics. A great significance has been garnered by cell separation in the fields of biology and medicine as it is a vital constituent of disease diagnosis and cellular therapy. A crucial role is played by cell separation methods in treating chronic diseases, like cancer and AIDS. Furthermore, it is extensively utilized in cancer research and stem cell research.
The growth of global cell separation technologies market is mainly driven by the rising cell therapy-focused research & development and growing occurrences of neurodegenerative diseases that increase the cell therapy’s need for treating the disease’s root cause. Further, escalated government expenditure in biotechnology field and development in cell separation technologies will also boost the market growth during the forecast period. Additionally, growing occurrence of chronic diseases, like cancer together with rise in government-led initiatives around the world to enhance their respective domestic biotechnology industry will fuel the growth of the market in the years to come.
The global cell separation technologies market can be bifurcated based on application, technology, and region. Based on technology, the market is segregated into surface markers separation and gradient centrifugation. Further, the surface markers separation is sub-divided into magnetic cell sorting and fluorescence activated cell sorting. Based on application, the market is classified into neuroscience research, oncology research, microbiology & immunology research, and stem cell research.
Regionally, the global cell separation technologies market is governed by North America owing to enhanced research infrastructure along with the escalated backing by government in life science field. Asia Pacific is also anticipated to witness substantial growth rate during the forecast period owing to the rising incidence of chronic diseases and improved healthcare infrastructure.
Few of the leading players actively contributing to the global cell separation technologies market consist of STEMCELL Technologies, Inc., Merck Millipore, Terumo BCT, Inc., Miltenyi Biotec GmbH, Life Technologies Corporation pluriSelect GmbH, and BD Biosciences, among others. Development of cutting-edge methods and easy cost-effective techniques can significantly bring up growth opportunities for the market players. To cite, in June 2020, a Stanford University spinout, Levitas Bio, was prepping for the introduction of a technology that seems to be almost unreal: magnetic levitation-based cell separation. Further, Akadeum Life Sciences declared progressions of next-gen cell isolation technologies in 2018. The firms had fruitfully verified microbubble for separation of human T cell.